These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4603758)

  • 21. [Monotherapy or polytherapy in epilepsy?].
    Reynolds EH; Shorvon SD; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Jun; 25(2):33-7. PubMed ID: 7339761
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Di-N-propylacetic acid in the epileptic syndrome].
    Broglia S; Colombo RS; Barberis F
    Clin Ter; 1972 Oct; 63(2):165-74. PubMed ID: 4566414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective study on epileptic patients treated with carbamazepine: interaction between age and co-medication on the drug disposition.
    Kumps A; Mardens Y
    Pharm Acta Helv; 1983; 58(5-6):160-4. PubMed ID: 6867050
    [No Abstract]   [Full Text] [Related]  

  • 26. Antinuclear antibodies in children with epilepsy treated by carbamazepine.
    Asadi-Pooya AA; Asadi-Pooya K
    Epilepsy Res; 2008 Aug; 80(2-3):229-30. PubMed ID: 18490144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tolerance and clinical action of carbamazepine under in a new suspension form, in 38 children and adolescents aged from 2 to 18, with epilepsy, sometimes complicated by behavior and character disorders].
    Sallou C
    Rev Neuropsychiatr Infant; 1975; 23(8-9):619-24. PubMed ID: 1108146
    [No Abstract]   [Full Text] [Related]  

  • 29. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with Tegretol in polygraphic sleep EEG].
    Maxion H
    Nervenarzt; 1968 Dec; 39(12):547-9. PubMed ID: 5733570
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiac effects of carbamazepine therapy].
    Checchini M; Magni M; Scaglione M; Vaccarella A
    Minerva Cardioangiol; 1995 Sep; 43(9):379-81. PubMed ID: 8552266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laser evoked potentials and carbamazepine in epileptic patients.
    Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G
    Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary report on our personal experience on the use of tegretol].
    Londoño R
    Neurocirugia; 1969; 27(1):180-3. PubMed ID: 5385644
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experiences with Tegretol in the treatment of epilepsy].
    Durdević M; Nikolić M
    Neuropsihijatrija; 1971; 19(1):65-70. PubMed ID: 5152607
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 36. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
    Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
    J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience with a new anticonvulsant in childhood seizures and epileptic behavior disorders].
    Nievoll A; Geyer N
    Wien Med Wochenschr; 1967 Sep; 117(35):788-92. PubMed ID: 4969463
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new anti-epileptic drug: Tegretol].
    Rey-Bellet J; Martin F; Tchicaloff M; Béboux JM
    Rev Med Suisse Romande; 1966 Jul; 86(7):439-55. PubMed ID: 5941948
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic surveillance of anti-epileptic drugs. Determination of dosage regimen and monitoring of treatment].
    Kumps A
    Acta Neurol Belg; 1982; 82(4):209-14. PubMed ID: 6814159
    [No Abstract]   [Full Text] [Related]  

  • 40. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.
    Attilakos A; Papakonstantinou E; Schulpis K; Voudris K; Katsarou E; Mastroyianni S; Garoufi A
    Epilepsy Res; 2006 Oct; 71(2-3):229-32. PubMed ID: 16889940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.